Riva-Atomoxetine 18 mg

RIVA-ATOMOXETINE 18 MG capsules are a selective norepinephrine reuptake inhibitor used to manage certain conditions. This medication is designed for oral administration and is manufactured by Laboratoire Riva Inc. in Canada.

RIVA-ATOMOXETINE 18 MG capsules are commonly used to help manage symptoms of attention deficit hyperactivity disorder (ADHD). This medication works by affecting certain chemicals in the brain that contribute to impulse control and hyperactivity. It is often prescribed as part of a comprehensive treatment plan that may include psychological, educational, and social therapies.

Common effects of RIVA-ATOMOXETINE 18 MG capsules may include dry mouth, decreased appetite, nausea, and stomach pain. Some individuals may also experience dizziness, fatigue, or mood changes. These effects can vary in intensity and duration depending on the individual.

RIVA-ATOMOXETINE 18 MG capsules should be handled with care and stored in a cool, dry place away from direct sunlight. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms.

RIVA-ATOMOXETINE 18 MG capsules may interact with certain medications, including other ADHD treatments, antidepressants, and drugs that affect blood pressure. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication.